Bringing rapid and accurate diagnostic testing where needed most
Ho-Jun Suk; Co-Founder & CEO, DXLab
P&G is looking for new disruptive ways (technology or research sensors/platform/physical and or digital solution) to run Observational Research for BabyCare among parents with babies 0-3yo and among pregnant mums throughout their day (in-home & during outings). P&G invites startups to submit scalable, cost-effective solutions by February 28 for pilot opportunities in North America and Europe. Submit your applications today for early consideration!
Murata is seeking startups to trial its innovative cell fractionation filter, CELLNETTA, to identify key challenges this product can solve.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
The Schlumberger-Doll Research Center (SDR) is gathering academia, incubators, CVCs and industry players working on energy and decarbonization.
Leading Global Brewer Looks to Partner with Startups for Innovative Solutions to Improve Core Business Processes and Lower Operational Costs
At P&G we recently announced our ambition to achieve net zero greenhouse gas emissions across our supply chain and operations by 2040, from raw material to retailer.
Looking for 8-10 startups to participate on April 10 in Lightning Talks and Lunch Exhibit at the 2024 MIT Health Science Technology Conference.